KLF7 (Krüppel-like factor 7) is a member of the Krüppel-like family of transcription factors, characterized by a conserved DNA-binding domain with three C?H? zinc fingers. It plays critical roles in regulating cellular processes such as differentiation, proliferation, and apoptosis. KLF7 is particularly notable for its involvement in nervous system development, where it promotes axonal regeneration and neuronal survival. Additionally, it influences metabolic pathways, including adipogenesis and glucose homeostasis, linking it to obesity and diabetes research.
The KLF7 antibody is a key tool for detecting and studying the expression, localization, and function of KLF7 protein in various biological contexts. Researchers use it in techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to investigate KLF7's role in diseases such as neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s), metabolic syndromes, and cancer. Its specificity is crucial for distinguishing KLF7 from other structurally similar Krüppel-like factors.
Recent studies highlight KLF7's dual role as both a tumor suppressor and oncogene, depending on tissue context, underscoring the need for reliable antibodies to clarify its mechanistic contributions. Validating KLF7 antibodies with knockout controls or siRNA-mediated knockdown remains essential to ensure accuracy in experimental models. Overall, KLF7 antibodies are vital for advancing our understanding of its diverse physiological and pathological functions.